Cargando…
Clinical features of thrombosis and bleeding in COVID-19
Infection with the SARS-CoV-2 virus, resulting in COVID-19 disease, has presented a unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is some three- to sixfold higher than for patients admitted to a hospital for other indications, and for patients who have throm...
Autores principales: | Thomas, Mari R., Scully, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040438/ https://www.ncbi.nlm.nih.gov/pubmed/35452509 http://dx.doi.org/10.1182/blood.2021012247 |
Ejemplares similares
-
COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022) -
Vasculopathy in COVID-19
por: Flaumenhaft, Robert, et al.
Publicado: (2022) -
COVID-19 in patients with hematologic malignancy
por: Langerbeins, Petra, et al.
Publicado: (2022) -
Cellular therapies for the treatment and prevention of SARS-CoV-2 infection
por: Conway, Susan R., et al.
Publicado: (2022) -
Thrombosis and Bleeding as Presentation of COVID-19 Infection with Polycythemia Vera. A Case Report
por: Chow, Lai Chee, et al.
Publicado: (2020)